MicroPort Scientific Corporation
MicroPort Scientific Corporation Fundamental Analysis
MicroPort Scientific Corporation (MCRPF) shows weak financial fundamentals with a PE ratio of 53.17, profit margin of 4.89%, and ROE of 6.07%. The company generates $1.1B in annual revenue with moderate year-over-year growth of 8.45%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 28.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MCRPF's fundamental strength across five key dimensions:
Efficiency Score
WeakMCRPF struggles to generate sufficient returns from assets.
Valuation Score
ModerateMCRPF shows balanced valuation metrics.
Growth Score
ExcellentMCRPF delivers strong and consistent growth momentum.
Financial Health Score
ModerateMCRPF shows balanced financial health with some risks.
Profitability Score
WeakMCRPF struggles to sustain strong margins.
Key Financial Metrics
Is MCRPF Expensive or Cheap?
P/E Ratio
MCRPF trades at 53.17 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, MCRPF's PEG of 0.42 indicates potential undervaluation.
Price to Book
The market values MicroPort Scientific Corporation at 2.64 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 22.39 times EBITDA. This signals the market has high growth expectations.
How Well Does MCRPF Make Money?
Net Profit Margin
For every $100 in sales, MicroPort Scientific Corporation keeps $4.89 as profit after all expenses.
Operating Margin
Core operations generate -3.73 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $6.07 in profit for every $100 of shareholder equity.
ROA
MicroPort Scientific Corporation generates $1.32 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
MicroPort Scientific Corporation generates limited operating cash flow of $-103.09M, signaling weaker underlying cash strength.
Free Cash Flow
MicroPort Scientific Corporation generates weak or negative free cash flow of $-187.95M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.10 in free cash annually.
FCF Yield
MCRPF converts -5.59% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
53.17
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.42
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.64
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.02
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.63
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.45
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.06
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
-0.01
vs 25 benchmark
How MCRPF Stacks Against Its Sector Peers
| Metric | MCRPF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 53.17 | 29.43 | Worse (Expensive) |
| ROE | 6.07% | 692.00% | Weak |
| Net Margin | 4.89% | -44295.00% (disorted) | Weak |
| Debt/Equity | 1.63 | 0.35 | Weak (High Leverage) |
| Current Ratio | 1.45 | 4.48 | Neutral |
| ROA | 1.32% | -18045.00% (disorted) | Weak |
MCRPF outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews MicroPort Scientific Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
23.55%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-801.58%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
-278.55%
Industry Style: Defensive, Growth, Innovation
Declining